10/06/2015
The Orphan Drug Act (ODA), passed by Congress in 1983, created economic incentives for pharmaceutical companies to pursue treatments for diseases that affect fewer than 200,000 individuals. What is the impact that the ODA has had on patients, patient-advocacy organizations, and the pharmaceutical in…